David H Brewster
Overview
Explore the profile of David H Brewster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1566
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mesa-Eguiagaray I, Wild S, Bird S, Williams L, Brewster D, Hall P, et al.
Breast Cancer Res Treat
. 2022 Jun;
194(2):463-473.
PMID: 35648299
Background: Women from socio-economically deprived areas are less likely to develop and then to survive breast cancer (BC). Whether associations between deprivation and BC incidence and survival differ by tumour...
2.
Menon U, Weller D, Falborg A, Jensen H, Butler J, Barisic A, et al.
Br J Cancer
. 2022 May;
127(5):844-854.
PMID: 35618787
Background: International Cancer Benchmarking Partnership Module 4 reports the first international comparison of ovarian cancer (OC) diagnosis routes and intervals (symptom onset to treatment start), which may inform previously reported...
3.
Cavers D, Duff R, Bikker A, Barnett K, Kanguru L, Weller D, et al.
BMC Cancer
. 2021 May;
21(1):496.
PMID: 33941114
Background: More people are surviving a first primary cancer and experiencing a second, different cancer. However, little is known about the diagnostic journeys of patients with second primary cancer (SPC)....
4.
Campbell C, Douglas A, Williams L, Cezard G, Brewster D, Buchanan D, et al.
BMJ Open
. 2020 Oct;
10(10):e037011.
PMID: 33033017
Objective: Cancer screening should be equitably accessed by all populations. Uptake of colorectal cancer screening was examined using the Scottish Health and Ethnicity Linkage Study that links the Scottish Census...
5.
Mesa-Eguiagaray I, Wild S, Rosenberg P, Bird S, Brewster D, Hall P, et al.
Br J Cancer
. 2020 Jun;
123(5):852-859.
PMID: 32555534
Background: We describe temporal trends in breast cancer incidence by molecular subtypes in Scotland because public health prevention programmes, diagnostic and therapeutic services are shaped by differences in tumour biology....
6.
Gray E, Marti J, Wyatt J, Brewster D, Hall P
PLoS Med
. 2020 Jan;
16(12):e1003006.
PMID: 31891574
Background: Adjuvant chemotherapy in early stage breast cancer has been shown to reduce mortality in a large meta-analysis of over 100 randomised trials. However, these trials largely excluded patients aged...
7.
Menon U, Vedsted P, Falborg A, Jensen H, Harrison S, Reguilon I, et al.
BMJ Open
. 2019 Nov;
9(11):e025895.
PMID: 31776134
Objective: Differences in time intervals to diagnosis and treatment between jurisdictions may contribute to previously reported differences in stage at diagnosis and survival. The International Cancer Benchmarking Partnership Module 4...
8.
Wright P, Wilding S, Watson E, Downing A, Selby P, Hounsome L, et al.
Cancer Epidemiol
. 2019 May;
60:201-207.
PMID: 31071525
Background: More men are living following a prostate cancer (PCa) diagnosis. They may need support to maximize the quality of their survival. Physical and psychological impacts of PCa are widely...
9.
Ruiz de Azua Unzurrunzaga G, Brewster D, Wild S, Sivalingam V
Cancer Epidemiol
. 2019 Mar;
59:227-231.
PMID: 30836220
Aim: The prevalence of hysterectomy is decreasing worldwide. It is not clear whether changes in the population at risk (women with intact uteruses) have contributed to an increased uterine cancer...
10.
Downing A, Wright P, Hounsome L, Selby P, Wilding S, Watson E, et al.
Lancet Oncol
. 2019 Feb;
20(3):436-447.
PMID: 30713036
Background: Little is known about the health-related quality of life (HRQOL) of men living with advanced prostate cancer. We report population-wide functional outcomes and HRQOL in men with all stages...